Tumour lymphangiogenesis plays an important role in promoting the growth and lymphatic metastasis of tumours. The process is associated with cell proliferation, migration and tube-like structure formation in lymphatic endothelial cells (LEC), but no antilymphangiogenic agent is currently used in clinical practice. Fucoxanthin is a material found in brown algae that holds promise in the context of drug development. 
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| INTRODUC TI ON
Fucoxanthin is an orange, non-pro-vitamin A carotenoid found in brown algae such as Undaria pinnatifida (Wakame) and Eisenia bicyclis (Arame) 1 . The structures of fucoxanthin (3′-acetoxy-5,6-epoxy-3,5′-dihydroxy-6′,7′-didehyro-5,6,7,8,5′,6′-hexahydro-β,β-carotene-8-one) is shown in Figure 1A . Fucoxanthin has recently been shown to exert important biological effects, including antitumour, antioxidant and antidiabetic activity 2 . Previous studies in human umbilical vein endothelial cells (HUVEC) have shown that fucoxanthin exerts an antiangiogenic effect that contributes to the prevention of cancer 3 .
Fucoxanthin prevents the proliferation of tumour cells through classical pathways involved in metastasis and the cell cycle, including the PI3K/Akt and nuclear factor kappa B (NF-κB) pathways 4 . Although fucoxanthin has been found to play an important role in human health, specific effects on tumour lymphatic metastasis remain to be Lymphangiogenic factors such as vascular endothelial growth factor (VEGF)-C, which binds to VEGF receptor-3 (VEGFR-3), increase the ability of lymphatic vessels to invade tumours 6 . Expression of VEGF-C was found to correlate with metastasis in human cancer 7, 8 .
In animal models, inhibition of lymphangiogenesis through blockade of VEGF-C or VEGFR-3 has been shown to prevent lymphatic metastasis. Ongoing studies are investigating the role of VEGFR-3 and VEGF-C/-D in tumour lymphangiogenesis, using soluble VEGFR-3 or antibodies to VEGFR-3 to inhibit tumour metastasis and lymphan-
Nuclear factor kappa B is another molecule that plays an important role in lymphangiogenesis. Nuclear factor kappa B is a transcription element located in the cytoplasm. Before release is triggered by a stimulus, NF-κB remains bound in an inert NF-kappa-B inhibitor (IκB) complex. On stimulation, a nuclear localization signal regulates transport of the activated NF-κB complex into the nucleus to induce related gene expression, in particular, VEGF-C, Cyclin D1, matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). Nuclear factor kappa B may be activated by numer- We hypothesized that ECM degradation might be of special con- mouse model of breast cancer. The fucoxanthin used was extracted from U pinnatifida. These experiments were designed to elucidate the mechanism underlying lymphangiogenesis to specific cellular targets.
| MATERIAL S AND ME THODS

| Preparation of fucoxanthin
Fucoxanthin was isolated from U pinnatifida and the preparation method as previously reported 14 . 
| Cell culture
| Cell viability
| Flow cytometry
Human LEC (1 × 10 6 cells/mL) were incubated for 24 hours at 37°C, then suspended in 500 μL 75% ice-cold ethanol for >2 hours at 4°C.
The resulting cell pellet was collected via centrifugation at 107 g for 5 minutes. Prior to incubation, 100 μL RNase A was added. Cell preparations were incubated for 30 minutes at 37°C. DNA staining was performed with propidium iodide (400 μL). Progression through the cell cycle was analysed with a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA).
| Migration assay
Transwells ( 
| Tube formation
Cell viability (%) =
Tube quantity control
| Immunohistochemistry
To stain the cytoskeleton, cells were fixed in 3.7% methylaldehyde for 10 minutes, washed with PBS containing 0.1%
TritonX-100 for 5 minutes, and then stained for 20 minutes at room temperature with green-fluorescent phalloidin (KeyGEN Biotech, Nanjing, China). Cell nuclei were identified by counterstaining with 4′,6-diamidino-2-phenylindole. After three washes, cells were examined under a fluorescent microscope (Leica, Solms, Germany).
| Western blot
To examine protein expression levels in HLEC after treatment with fucoxanthin, cells were treated with fucoxanthin for 24 hours, then lysed in RIPA lysis buffer (Thermo scientific, Waltham, MA, USA). Equivalent amounts of protein (40 μg) were measured using the Bradford method and resolved by 12% SDS-PAGE gels, which were electrotransferred onto nitrocellulose membranes. Membranes were incubated overnight at 4°C with relevant primary and peroxidase-conjugated secondary antibodies. Protein bands were detected with an ECL system (Bio-Rad Laboratories, Hercules, CA). The following primary antibodies were used: human anti-p-PI3K, p-Akt, NF-κB, VEGF-C, VEGFR-3, MMP-2, MMP-9, TIMP-1(1:500) and anti-GAPDH (the latter as internal control).
| Quantitative real-time PCR (Real-time qPCR)
Cells treated with fucoxanthin were cultured for 24 hours. TRIzol reagent (Invitrogen, Carlsbad, CA) was used to extract total RNA. Reverse-transcription used an oligo(dT) primer and Murine Leukemia Virus reverse transcriptase (Takara, Dalian, China) to obtained cDNA GAPDH was used as internal control. The following primers were used: GAPDH, 5′-TGGCACCCAGCACAATGAA-3′ and 5′-CTAAGTCATAGTCCGCCTAGAAG CA-3′; VEGF-C, 5′-ATTAGACGTTC CCTGCCAGC-3′ and 5′-TCCAGCTCCTTGTTTGGTCC-3′; VEGFR-3, 5′-ATTCCCCATGACCCCAACGA-3′ and 5′-GTAAAA CACCTGGCCTCCTCG-3′.
Real-time qPCR was performed in triplicate for every sample in a parallel design, using the SYBR ® Premix ExTaq ™ (Takara) and the Takara detection system TaKaRa TP800 (Dalian, China), according to the manufacturer's protocol. Subsequently, the genes expression data were analysed by Thermal Cycler Dice Real Time system software (Takara), and quantified by the comparative cycle threshold (Ct) method (2 −ΔΔCt method), based on the Ct values for among VEGFC, VEGFR3 and GAPDH to calculate the relative fold increase.
| Conditional culture
Briefly, MDA-MB-231 cells were treated with fucoxanthin (25, 50, 100 μmol/L) for 24 hours and cultured with serum-free medium for 24 hours. Supernatant was centrifuged and collected. Human LEC were cultured with 40% conditional medium for assays of tube formation. 
| Lymphangiogenesis in vivo
| Statistical analysis
Data are expressed as mean ± SD. Significant differences were evaluated by one-way ANOVA using spss and Prism 5 (Version 5.04, GraphPad Software, Inc, La Jolla, CA). Statistical significance was defined as P < 0.05 and P < 0.01. All experiments were performed at least three times for quantitative comparison.
| RE SULTS
| Fucoxanthin inhibits the growth and proliferation of HLEC
The effect of fucoxanthin (25, 50 , 100 μmol/L) on viability and proliferation of HLEC over time (12, 24 , 48 hours) was evaluated by MTT assay.
Our data, as shown in Figure 1B 
| Fucoxanthin inhibits tube formation in HLEC
Tube formation of HLEC was assessed to investigate the antilymphangiogenic effect of fucoxanthin. Tube formation capacity was inhibited in HLEC treated with fucoxanthin for 24 hours (Figure 2A Treatment with fucoxanthin decreased levels of phospho-VEGFR3 in a concentration-dependent manner ( Figure 2E ).
| Fucoxanthin inhibits HLEC migration
To evaluate the effects of fucoxanthin on HLEC migration, we performed Transwell assays as well as cytoskeletal and nuclear staining. 
| Fucoxanthin suppresses PI3K/Akt/NF-κB signalling
In order to elucidate the mechanism underlying the inhibitory effect of fucoxanthin on lymphangiogenesis in HLEC, PI3K/Akt/NF- 
| Fucoxanthin affects malignant phenotypes of MDA-MB-231 cells in vitro
| Fucoxanthin inhibits tumour-induced lymphangiogenesis in vitro
Cell growth, migration and tube formation were investigated using a 24-hour conditional culture system in order to further analyse whether fucoxanthin inhibited tumour-induced lymphangiogenesis.
Cell viability, migration and tube formation were significantly in- levels of phospho-VEGFR3 ( Figure 5C ). These results indicate decreased levels of VEGF-C in MDA-MB-231 cells.
| Inhibition of tumour growth and lymphangiogenesis in a mouse model
Fucoxanthin-mediated inhibition of tumour growth and lymphangiogenesis were investigated in a MDA-MB-231 breast cancer xenograft model using Balb/c nude mice. The results showed that fucoxanthin significantly decreased tumour volume ( Figure 6A,B) and weight ( Figure 6C ).
Tumour lymphangiogenesis was analysed using immunofluo- 
| D ISCUSS I ON
Metastasis is a feature used for tumour classification as well as a common cause of cancer-related death. Metastasis via lymphatic vessels is an important initial event. Tumour-induced lymphangiogenesis in regional lymph nodes or local tumours has been associated with formation of various types of tumours, including breast cancers 15 . In 
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